Therapeutic Expertise

Endocrine Disorders

Advanced Therapies For Diabetes and Weight Management

With over three decades of experience in clinical research, we have been involved in various groundbreaking trials, particularly those focused on innovative treatments for Type 2 Diabetes (DM2) and weight loss, including the use of Tirzepatide and Semaglutide. These medications are at the forefront of improving both glycemic control and promoting significant weight reduction, and we have had the privilege of helping participants bring their HbA1c levels closer to their health goals while supporting healthy weight management.

Beyond facilitating access to these advanced therapies, we prioritize community education, emphasizing the importance of daily blood glucose monitoring. Teaching patients proper methods to verify their sugar levels is crucial for long-term diabetes and weight management, empowering them to take control of their health and make informed decisions. Working with these transformative technologies and medications and seeing the positive impacts on participants’ lives has been incredibly rewarding.

Liver Disease

MASH and MASLD

We are committed to advancing the clinical development of therapeutics for Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Collaborating with leading experts in the field, our mission is to enhance the understanding of these conditions while providing participants and their families with knowledge and comfort throughout the trial process. As the prevalence of liver diseases rises, we are dedicated to providing patients with the necessary diagnostic tools, including MRIs and liver biopsies, which are needed to define and combat this disease. We accomplish this by working closely with trusted vendors to ensure seamless and efficient care.

Infectious Diseases

Vaccination

Our work on COVID-19 and flu vaccines has placed us at the forefront of healthcare advancements, making a meaningful impact on our communities by prioritizing their health and safety. We have a deep commitment to ensuring that our clinical trials not only push the boundaries of science but also address urgent public health needs. Our specialized PK trials, which often require extensive 12- to 24-hour blood collections, are meticulously managed by our expert team and dedicated investigators. Together, we ensure that we meet our enrollment timelines while maintaining the highest standards of care and precision in every step of the research process.

Central Nervous System

Psychiatric and Neurological Disorders

The Concierge Clinical Trial clinical scientists collectively bring more than three decades of expertise in the development and execution of clinical trials for psychiatric and neuropsychiatric disorders, including anxiety disorders, major depressive disorder, bipolar disorder, schizophrenia, Alzheimer’s Disease, Parkinson’s Disease, and related CNS conditions. Our team’s experience spans the full clinical development continuum—from early-phase studies integrating pharmacodynamic biomarkers and dose-response signal detection, to rigorous safety monitoring and characterization of emerging adverse events, and through later-stage trials requiring meticulous administration of sensitive psychometric rating scales to reliably demonstrate efficacy over placebo and active comparators.

This expertise is anchored by senior leadership with decades of hands-on experience designing, leading, and overseeing hundreds of psychiatry and CNS trials, supported by extensive publications and long-standing collaboration with sponsors and regulators. Our investigators and staff are highly trained in rater methodology, placebo mitigation strategies and regulatory-ready data collection, enabling us to proactively address common risks in psychiatric trials such as signal dilution, assessment variability, and dosing uncertainty. Together, this depth of experience allows us to deliver scientifically rigorous, operationally efficient studies with high data integrity across all phases of psychiatric drug development. Please review our CVs for additional detail on the breadth and depth of our team’s experience.